Accession | ARO:3007558 |
Definition | 5-Flucytosine is an antibiotic, particularly antifungal. It inhibits fungal RNA and DNA synthesis by changing the amino-acylation of tRNA, causing the amino acid pool to be altered and protein synthesis to be inhibited. |
SMILES | N/A |
PubChem | 3366 |
Drug Class | pyrimidine antifungal drug |
Classification | 2 ontology terms | Show |
Parent Term(s) | 1 ontology terms | Show + pyrimidine antifungal drug [Drug Class] |
Sub-Term(s) | 5 ontology terms | Show + Candida spp. FUR1 with mutations conferring resistance to 5-flucytosine confers_resistance_to_antibiotic + Saccharomyces spp. FUR1 with mutations conferring resistance to 5-flucytosine confers_resistance_to_antibiotic + Cryptococcus spp. UXS1 conferring resistance to 5-flucytosine via absence confers_resistance_to_antibiotic + Aspergillus spp. fcyB conferring resistance to 5-flucytosine via reduced permeability confers_resistance_to_antibiotic + Candida spp. FCY2 conferring resistance to 5-flucytosine via reduced permeability confers_resistance_to_antibiotic |
Publications | Sigera LSM, et al. 2023. Ther Adv Infect Dis 10:20499361231161387 Flucytosine and its clinical usage. (PMID 37051439) |
Curator | Description | Most Recent Edit |
---|